Premier Pharmacy Labs has voluntarily recalled several lots of injectable drug products, primarily opioid pain relievers, due to possible microbial contamination, the Food and Drug Administration announced yesterday. Hospitals and other health care facilities should stop using and return any recalled products to the company as described in a certified letter sent to all affected customers. Any adverse reactions or quality problems experienced with the products may be reported to the FDA's MedWatch program.

Related News Articles

Headline
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
Headline
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…
Headline
The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain…
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…